Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission

NCT00115648 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3300

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Nevirapine
DRUG: AZT
DRUG: NVP and AZT
DRUG: NVP
DRUG: NVP+AZT

Sponsor

Johns Hopkins Bloomberg School of Public Health

Collaborators

[object Object]
[object Object]